ABBOTT LABORATORIES INC.

Abbott Laboratories Inc. specializes in the manufacturing and supply of advanced electromedical and surgical systems, with deep expertise in cardiac rhythm management, electrophysiology mapping, and minimally invasive therapeutic devices. Their core capabilities center on the design, integration, and support of complex medical instrumentation including the EnSite EP Systems, LVAD platforms, and transcatheter valve technologies such as MitraClip and Aveir. The contractor delivers end-to-end solutions for diagnostic and interventional cardiology, integrating advanced software licenses for cardiac mapping, automated lesion marking, and real-time anatomical reconstruction. Technical proficiency spans FDA-regulated medical device manufacturing, clinical system calibration, and secure deployment of implantable and external electrophysiology hardware in high-acuity environments. The contractor maintains a strong, sustained relationship with the Department of Defense and the Department of Veterans Affairs, supplying critical cardiac care equipment for military medical facilities and VA hospitals. Work for these agencies focuses on procuring life-sustaining electrophysiology systems, implantable devices, and associated accessories to support veteran and service member cardiovascular care, often through direct sole-source engagements due to proprietary technology and clinical specificity. Industry focus is anchored in surgical and medical instrument manufacturing (NAICS 339112), surgical appliance manufacturing (339113), and electromedical apparatus production (334510), positioning Abbott Laboratories Inc. as a niche provider of high-acuity cardiac intervention systems. The contractor also supports the medical equipment wholesale supply chain (423450), ensuring timely logistics of specialized devices to federal medical centers. Operating as a 2L entity from Santa Clara, California, Abbott Laboratories Inc. holds no federal certifications but maintains rigorous compliance with FDA QSR and ISO 13485 standards through its manufacturing and quality systems. The company is strategically positioned within the federal healthcare supply chain as a trusted source for proprietary, clinically validated cardiac technologies.